menu icon

Investment

Expand trading menu on Pluang app
Navigation icon on Pluang platform
Invest in the world’s largest market with US Stocks

Features

Expand trading menu on Pluang app
Pluang support - get 24/7 expert trading help
Pro Tools for Pro Traders
Uncover the powerful trading features

Pro Features

Navigation icon on Pluang platform
Pluang support - get 24/7 expert trading help
Built for Investors
Experience investing with simplified features

Pockets

Navigation icon on Pluang platform

Fees

Safety

Academy

Expand trading menu on Pluang app

More

Expand trading menu on Pluang app
Pluang support - get 24/7 expert trading help
Support

About Us

Browse Pluang investment products menu

Pluang+

|

Asset icon - trade crypto, stocks, and gold on Pluang

Amgen, Inc. (AMGN) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Overview

Financial

Technicals

Analysis

Corporate Action

About

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Technical Indicators

|

|

|

Overall Summary

Bearish (8)

Neutral (6)

Bullish (13)


Performance

AMGN ROI

arrow
-17.68%

% from 52W High

-18.88%
$273.68

52W Low: $258.59

06 Jan 2025

52W High: $337.38

20 Sep 2024


News

Trading information on Pluang platform
Trading information on Pluang platform

Globe Newswire

7 day ago

Global Industrial Biomanufacturing Market Report 2026-2036: Sustainability, Synthetic Biology, and Circular Economy Drive Growth



People Also Bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions



Let’s trade or invest in this asset by signing up or logging in!

Pluang investment platform illustration - crypto, stocks, and gold

Let’s trade or invest in this asset by signing up or logging in!

You can also download our app!

Pluang mobile app - trade crypto, stocks, and gold anytime